Informações de Cigna Group | Histórico, dados financeiros e desempenho de mercado

Informações de Cigna Group Empresa

Informações da empresa

Código da empresaCI

Nome da EmpresaCigna Group

Data de listagemApr 01, 1982

Fundado em2018

CEOMr. Eric P. Palmer

Funcionários73500

Tipo de TítulosOrdinary Share

Fim do ano fiscalApr 01

Endereço- -

Cidade- -

Bolsa de ValoresNYSE Consolidated

País- -

Código postal- -

Telefone- -

Site- -

Código da empresaCI

Data de listagemApr 01, 1982

Fundado em2018

Executivos da Empresa

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. David M. Cordani, CPA

Chairman of the Board, President, Chief Executive Officer

653.62K

-3.90%

Mr. Brian C. Evanko

Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare

60.38K

+20.44%

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

29.75K

+28.79%

Ms. Donna F. Zarcone, CPA

Independent Director

26.09K

+2.11%

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

+2.45%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President and Chief Health Officer

9.04K

-3.11%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

5.47K

+10.93%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

5.47K

--

Ms. Kathleen M. Mazzarella

Independent Director

5.47K

+10.93%

Ms. Kimberly A. Ross

Independent Director

3.87K

+16.16%

Ver Mais

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. David M. Cordani, CPA

Chairman of the Board, President, Chief Executive Officer

653.62K

-3.90%

Mr. Brian C. Evanko

Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare

60.38K

+20.44%

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

29.75K

+28.79%

Ms. Donna F. Zarcone, CPA

Independent Director

26.09K

+2.11%

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

+2.45%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President and Chief Health Officer

9.04K

-3.11%

Detalhamento da Receita

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.47B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.05B

0.00%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.47B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.05B

0.00%

Acionista

Tempo de atualização: sex, 21 de fev

Estatísticas do Acionista

Tipo

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.49%

BlackRock Institutional Trust Company, N.A.

4.89%

State Street Global Advisors (US)

4.64%

MFS Investment Management

4.10%

T. Rowe Price Associates, Inc.

3.86%

Other

73.00%

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.49%

BlackRock Institutional Trust Company, N.A.

4.89%

State Street Global Advisors (US)

4.64%

MFS Investment Management

4.10%

T. Rowe Price Associates, Inc.

3.86%

Other

73.00%

Tipo

Acionista

Proporção

Investment Advisor

41.63%

Investment Advisor/Hedge Fund

39.78%

Pension Fund

2.42%

Research Firm

2.24%

Hedge Fund

1.99%

Bank and Trust

1.66%

Sovereign Wealth Fund

1.26%

Corporation

1.25%

Holding Company

0.43%

Other

7.30%

Instituição Participações

Tempo de atualização: dom, 19 de jan

Período do Relatório

Nº de instituições

Ações detidas

Proporção

Variação

2025Q1

2874

255.12M

93.18%

-3.90M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.88M

2024Q1

2865

261.01M

89.38%

-14.29M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.62M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

2023Q1

2710

268.82M

90.70%

-14.56M

2022Q4

2688

273.81M

91.52%

-15.32M

Ver Mais

Atividade dos Acionistas

Nome

Ações detidas

Proporção

Variação

Chg %

Data

The Vanguard Group, Inc.

25.97M

9.49%

+22.81K

+0.08%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.38M

4.89%

+8.79K

+0.06%

Dec 31, 2024

State Street Global Advisors (US)

12.71M

4.64%

-105.72K

-0.82%

Dec 31, 2024

MFS Investment Management

11.22M

4.1%

+489.58K

+4.55%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.56M

3.86%

-1.11M

-9.58%

Dec 31, 2024

Fidelity Management & Research Company LLC

9.98M

3.64%

-1.67M

-14.37%

Dec 31, 2024

Dodge & Cox

8.77M

3.2%

-16.80K

-0.19%

Dec 31, 2024

Sanders Capital, LLC

8.05M

2.94%

+154.41K

+1.95%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.95M

2.17%

+101.73K

+1.73%

Dec 31, 2024

GQG Partners, LLC

4.02M

1.46%

+737.09K

+22.44%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Tempo de atualização: há 14 horas

Nome

Proporção

Future Fund Active ETF

12.58%

iShares U.S. Healthcare Providers ETF

9.88%

Monarch Dividend Plus Index ETF

5.07%

Cambria LargeCap Shareholder Yield ETF

4.21%

VictoryShares Free Cash Flow ETF

4.05%

First Trust Large Cap US Equity Select ETF

3.21%

Davis Select US Equity ETF

3.15%

Fidelity Blue Chip Value ETF

2.41%

Hennessy Stance ESG ETF

2.39%

Brandes US Value ETF

2.36%

Ver Mais

Future Fund Active ETF

Proporção12.58%

iShares U.S. Healthcare Providers ETF

Proporção9.88%

Monarch Dividend Plus Index ETF

Proporção5.07%

Cambria LargeCap Shareholder Yield ETF

Proporção4.21%

VictoryShares Free Cash Flow ETF

Proporção4.05%

First Trust Large Cap US Equity Select ETF

Proporção3.21%

Davis Select US Equity ETF

Proporção3.15%

Fidelity Blue Chip Value ETF

Proporção2.41%

Hennessy Stance ESG ETF

Proporção2.39%

Brandes US Value ETF

Proporção2.36%

Dividendo

Um total de 5.74B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro das ações

Data de pagamento

Data de ex-dividendo

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

Ver Mais

Desdobramento de Ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Cigna Group

309.126USD

Cigna Group

309.126

Visão Geral

Empresa